A Study of Ketorolac for the Treatment of Inflammation and Pain Associated With Cataract Surgery

• Status: Completed
• Trial end date: 2008-03-01
• Target enrollment: 0
• Participant gender: All

Summary

This is a 16 day study to evaluate the safety and efficacy of ketorolac eye drops for the treatment of inflammation and pain associated with cataract surgery

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Allergan
• Treatments: Ketorolac; Ketorolac Tromethamine; Ophthalmic Solutions

Criteria

Inclusion Criteria:

• Patients undergoing cataract surgery

Exclusion Criteria:

• Uncontrolled ocular disease in cataract surgery eye